Prostate Screening EpiSwitch (PSE) blood test shows significant potential as an accurate and rapid cancer screening diagnostic High accuracy (94%), PPV (92%), and NPV (94%) reported in the high-impact ...
A new blood test for prostate cancer that offers greater accuracy than prostate-specific antigen (PSA) has been put to the test by researchers at the University of East Anglia (UEA) in collaboration ...
Researchers at the University of East Anglia have helped develop a new blood test to detect prostate cancer with greater accuracy than current methods. New research shows that the Prostate Screening ...
The receipt of a reimbursement code for the Episwitch Prostate Screening (PSE) test developed by Oxford Biodynamics plc, following its recent launch, is good news for men frustrated with the ...
The Board of Oxford BioDynamics Plc (AIM: OBD, the Company), a precision clinical diagnostics company bringing specific and sensitive tests to the practice of medicine based on its EpiSwitch® 3D ...
Researchers at the University of East Anglia have helped develop a new blood test to detect prostate cancer with greater accuracy than current methods. New research shows that the Prostate Screening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback